Fruquintinib provides meaningful benefit in refractory metastatic colorectal cancer
For patients with refractory metastatic colorectal cancer, fruquintinib treatment yields a significant and clinically meaningful benefit in terms of overall survival, according to a study published in the July 1 issue of ...
Jul 20, 2023
0
1